KR20220084011A - Pnpp-19의 눈 질환 예방 및 치료를 위한 방법 및 용도 - Google Patents

Pnpp-19의 눈 질환 예방 및 치료를 위한 방법 및 용도 Download PDF

Info

Publication number
KR20220084011A
KR20220084011A KR1020227006863A KR20227006863A KR20220084011A KR 20220084011 A KR20220084011 A KR 20220084011A KR 1020227006863 A KR1020227006863 A KR 1020227006863A KR 20227006863 A KR20227006863 A KR 20227006863A KR 20220084011 A KR20220084011 A KR 20220084011A
Authority
KR
South Korea
Prior art keywords
pnpp
eye
glaucoma
peptide
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020227006863A
Other languages
English (en)
Korean (ko)
Inventor
실바 쿤하 주니어 아르만도 다
리마 페레즈 가르시아 마리아 엘레나 데
다 실바 카롤리나 누니스
누니스 두라도 레이즈 페르난다
볼지스 다 실바 펄라 빌라니
삼파이오 라카티바 파울로 구스타보
그로스 게르하드 막스
데 파울라 주니오르 아이언 프란시스코
Original Assignee
바이오제우스 데센볼비멘토 데 프로듀토스 바이오파르마세우티코스
유니버시다드 페드럴 데 미나스 게라이스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이오제우스 데센볼비멘토 데 프로듀토스 바이오파르마세우티코스, 유니버시다드 페드럴 데 미나스 게라이스 filed Critical 바이오제우스 데센볼비멘토 데 프로듀토스 바이오파르마세우티코스
Publication of KR20220084011A publication Critical patent/KR20220084011A/ko
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
KR1020227006863A 2019-09-03 2020-09-01 Pnpp-19의 눈 질환 예방 및 치료를 위한 방법 및 용도 Abandoned KR20220084011A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962895252P 2019-09-03 2019-09-03
US62/895,252 2019-09-03
US17/008,794 2020-09-01
US17/008,794 US20210060125A1 (en) 2019-09-03 2020-09-01 METHOD AND USE OF PnPP-19 FOR PREVENTING AND TREATING EYE DISEASES
PCT/BR2020/050349 WO2021042193A1 (en) 2019-09-03 2020-09-01 Method and use of pnpp-19 for preventing and treating eye diseases

Publications (1)

Publication Number Publication Date
KR20220084011A true KR20220084011A (ko) 2022-06-21

Family

ID=74682721

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227006863A Abandoned KR20220084011A (ko) 2019-09-03 2020-09-01 Pnpp-19의 눈 질환 예방 및 치료를 위한 방법 및 용도

Country Status (8)

Country Link
US (1) US20210060125A1 (https=)
EP (1) EP4025234A4 (https=)
JP (1) JP2022547231A (https=)
KR (1) KR20220084011A (https=)
CN (1) CN114302734A (https=)
BR (1) BR112022003759A2 (https=)
CA (1) CA3147704A1 (https=)
WO (1) WO2021042193A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024168415A1 (en) * 2023-02-17 2024-08-22 Biozeus Biopharmaceutical S.A. Topical peptide formulation for the treatment of sexual dysfunction
WO2025133214A1 (en) 2023-12-21 2025-06-26 Novaliq Gmbh Ophthalmic polypeptide compositions for the treatment of posterior eye disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005097137A (ja) * 2003-09-22 2005-04-14 Tokyoto Igaku Kenkyu Kiko 糖尿病性網膜症の予防又は治療剤
JP2011219412A (ja) * 2010-04-09 2011-11-04 Saisentan Igaku Kenkyusho:Kk 緑内障の視野改善治療薬
US8759298B2 (en) * 2010-05-03 2014-06-24 Scott & White Healthcare Protein therapy for corneal inflammation, epithelial wound healing, and photoreceptor degeneration
MX362058B (es) * 2012-08-20 2019-01-07 Univ Federal De Minas Gerais Ufmg Péptido pntx(19) sintético, composición farmacéutica y uso.
GB201401453D0 (en) * 2014-01-28 2014-03-12 Univ Birmingham Transmucosal and transepithelial drug delivery system
BR102014010268B1 (pt) * 2014-04-29 2021-12-28 Universidade Federal De Minas Gerais - Ufmg Uso do peptídeo sintético pntx-19 para tratamento de dor
WO2017068388A2 (pt) * 2015-09-18 2017-04-27 Universidade Federal De Minas Gerais - Ufmg Uso do peptideo sintetico pntx-19 para tratamento de dor

Also Published As

Publication number Publication date
BR112022003759A2 (pt) 2022-05-31
JP2022547231A (ja) 2022-11-10
US20210060125A1 (en) 2021-03-04
CN114302734A (zh) 2022-04-08
CA3147704A1 (en) 2021-03-11
EP4025234A1 (en) 2022-07-13
WO2021042193A1 (en) 2021-03-11
EP4025234A4 (en) 2023-09-20

Similar Documents

Publication Publication Date Title
US11273197B2 (en) Adiponectin peptidomimetics for treating ocular disorders
Huang et al. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia
US20180296630A1 (en) Methods and compositions for preventing or treating ophthalmic conditions
Li et al. Glaucoma and ocular surface disease: more than meets the eye
US11918577B2 (en) Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodegenerative diseases
CA3095073A1 (en) Sap and peptidomimetics for treatment of eye disease
KR101906494B1 (ko) 콜라겐 타입 ι 및 색소 상피성 인자 펩타이드를 유효성분으로 함유하는 신생혈관질환 예방 또는 치료용 약학조성물
KR20220084011A (ko) Pnpp-19의 눈 질환 예방 및 치료를 위한 방법 및 용도
HK40027227A (en) Adiponectin peptidomimetics for treating ocular disorders
JP2020535117A (ja) 眼疾患を治療するためのアディポネクチンペプチド模倣薬

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20220228

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1902 Submission of document of abandonment before decision of registration